15
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Luteinizing Hormone Secretion during Continuous or Pulsatile Infusion of Norepinephrine: Central Nervous System Desensitization to Constant Norepinephrine Input

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The luteinizing hormone (LH) secretory response to continuous or pulsatile infusion of norepinephrine (NE) into the third ventricle was compared in ovariectomized, steroid-primed rats. Unanesthetized rats were bled continuously through external jugular cannulae at rates of 40 or 75 μl whole blood every 5 or 6 min, respectively, for up to 30 min prior to infusion, and for 3 h during continuous or pulsatile infusion of NE. Animals not infused, and those receiving continuous infusion with artificial cerebrospinal fluid or 11 μg NE/h showed no change in LH release. Continuous infusion with 18 or 22 μg NE/h increased LH secretion, blood LH levels being elevated for the initial 40–60 min of infusion. By 60–80 min, however, blood LH levels had returned to preinfusion values and remained there for 2 h despite continuous NE infusion. This rapid desensitization of the LH secretory system to continuous NE input was not pituitary-mediated, since comparable LH secretion occurred when a single injection of 3 ng luteinizing hormone-releasing hormone (LHRH) was given intravenously 2 h after the onset of a 3-hour continuous infusion of either 18 μg NE/h (i.e. during the desensitization period) or cerebrospinal fluid. In contrast, pulses of NE (6 μg/2 min) given once per hour for 3 h produced increases in LH secretion with each hourly pulse. To further test the importance of the pattern of NE administration, infusion of NE at the rate of 18 μg/h was repeated except that the infusion was either turned on for 20 min, off for 120 min, and then on for 40 min, or turned on for 40 min, off for 80 min, and then on for 60 min. In both experiments LH secretion increased during the first stimulation period, declined to control levels when the infusion was turned off, but now increased in response to the second NE infusion period. These studies demonstrate that the desensitization of the LH secretory system to continuous NE input is not caused by a refractoriness of the pituitary gland to LHRH,but is instead centrally mediated. LHRHneurons (or in-terneurons mediating the NE signal) respond best to pulsatile NE stimulation, and rapidly become desensitized to continuous NE input.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1982
          1982
          26 March 2008
          : 35
          : 5
          : 380-387
          Affiliations
          Department of Physiology, University of California, School of Medicine, San Francisco, Calif., USA
          Article
          123411 Neuroendocrinology 1982;35:380–387
          10.1159/000123411
          7145029
          4ca99ccc-31c3-4733-bfb1-10e2e98cab25
          © 1982 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 12 March 1982
          : 01 June 1982
          Page count
          Pages: 8
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Luteinizing hormone-releasing hormone,Norepinephrine,Anterior pituitary,Luteinizing hormone,Desensitization

          Comments

          Comment on this article